Affiliation:
1. Prof.Dr.Cemil Tascioglu City Hospital
2. Prof.Dr Cemil Taşçıoğlu Şehir Hastanesi
Abstract
Background/Aims:
Investigation of the efficacy of adjuvant RT in cervical cancer stage I-IIA according to FIGO (2018) in terms of risk factors and oncologic outcomes.
Methods:
The study included 113 patients with FIGO stage I-IIA. Patients who received adjuvant external pelvic RT and/or intracavitary brachytherapy (ICBT) after surgery retrospectively analyzed for demographic data , histology, grade, tumor size , stage, LVSI, stromal invasion depth, type of lymphadenectomy, number of dissected pelvic / paraaortic lymph nodes , surgical margin, adjuvant therapies, local relapse, distant failure, overall survival, and progression-free survival.
Results:
After a median follow-up of 160 months, local recurrence was observed in 3 patients, distant metastasis in 6 patients and all-cause death in 15 patients. It was observed that only SID had a statistically significant effect on overall survival among the Sedlis criteria (p=0.04). The ten-year DFS and OS rates were 95% and 94%, respectively .
Conclusions:
Promising oncological results were obtained in early stage cervical cancer with adjuvant RT based on Sedlis criteria.
Publisher
Cagdas Tip Dergisi: Journal of Contemporary Medicine